(PDF/71.58 KB)
Throw it away after one use, even if there is still medicine left inside.Your dose needs may change if you switch to a different brand, strength, or form of this medicine. Call your pharmacist for new medicine.Each single-use prefilled syringe or autoinjector is for one use only. (PDF/49.18 KB) Do not use if the medicine has changed colors or has particles in it. The Aimovig autoinjector is a medical device that contains one prefilled dose of medicine in a spring-loaded syringe.
(PDF/88.53 KB) (PDF/93.88 KB) (PDF/40.25 KB) (PDF/34.5 KB)
(PDF/2.05 MB) (PDF/26.59 KB)
(PDF/1.97 MB) Aimovig (erenumab-aooe) works by blocking the calcitonin gene-related peptide (CGRP) receptor binding site and function. (PDF/2.05 MB) (PDF/1.76 MB) (PDF/96.46 KB) However, having migraine headaches during pregnancy may cause complications such as preeclampsia (dangerously It may not be safe to breastfeed while using this medicine. (PDF/98.33 KB) (PDF/71.65 KB) (PDF/72.84 KB) Aimovig is a medicine used one time per month to help prevent migraine headaches. (PDF/26.58 KB) (PDF/1.79 MB) You may report side effects to FDA at 1-800-FDA-1088.Other drugs may interact with erenumab, including prescription and over-the-counter medicines, Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Aimovig only for the indication prescribed.Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.Copyright 1996-2020 Cerner Multum, Inc. Cramps, muscle spasms, allergic reactions and high blood pressure have also been reported. (PDF/1.75 MB) Aimovig (erenumab-aooe), a medicine used for migraine prevention, did not lead to hair loss (alopecia) during clinical trials submitted for FDA-approval. (PDF/1.85 MB) (PDF/91.17 KB) (PDF/71.58 KB) If your healthcare provider prescribes the 140 mg dose for you, take two separate injections one after another, using a different prefilled autoinjector or prefilled syringe for each injection. (PDF/102.14 KB) (PDF/90.52 KB) (PDF/94.77 KB) (PDF/89.76 KB) CGRP is a protein thought to cause blood vessels to dilate and lead to inflammation and migraine headache pain. The dosing, side effects, effectiveness and costs of these medicines can vary. (PDF/87.66 KB) (PDF/22.99 KB) (PDF/1.76 MB) (PDF/1.75 MB) (PDF/94.77 KB) (PDF/103.56 KB) Patients can inject the medicine themselves after being trained.The recommended dose is 70 mg every 4 weeks as a single injection. Do not use Aimovig ® if you are allergic to erenumab-aooe or any ingredients in Aimovig ®. (PDF/102.14 KB)
Ask your doctor about any risk.Use Aimovig exactly as directed by your healthcare provider.
(PDF/86.06 KB) (PDF/49.18 KB) Erenumab, sold under the brand name Aimovig, is a medication which targets the calcitonin gene-related peptide receptor (CGRPR) for the prevention of migraine. The United Kingdom (UK) withdrew from the European Union (EU) on 31 January 2020 and is no longer an EU Member State.
(PDF/72.4 KB) EMA is in the process of making appropriate changes to this website.